Application of the Crystal Structure of the SARS-CoV-2 Spike Protein for the Development of a Peptide Vaccine against Virus
- Авторлар: Ivanovsky A.S.1, Kolesnikov I.A.2, Kordonskaya Y.V.2,1, Ermakov A.V.2, Marchenkova M.A.2,1, Timofeev V.I.2,1, Pisarevsky Y.V.1,2, Dyakova Y.A.2, Kovalchuk M.V.2,1
-
Мекемелер:
- Shubnikov Institute of Crystallography, Federal Scientific Research Centre “Crystallography and Photonics,” Russian Academy of Sciences, 119333, Moscow, Russia
- National Research Centre “Kurchatov Institute”, 123182, Moscow, Russia
- Шығарылым: Том 68, № 6 (2023)
- Беттер: 955-958
- Бөлім: КРИСТАЛЛОГРАФИЯ В БИОЛОГИИ И МЕДИЦИНЕ
- URL: https://ter-arkhiv.ru/0023-4761/article/view/673310
- DOI: https://doi.org/10.31857/S0023476123600349
- EDN: https://elibrary.ru/ABZIFA
- ID: 673310
Дәйексөз келтіру
Аннотация
Based on the spike protein of the SARS-CoV-2 virus, a protein capable of causing an immune answer has been predicted. The protein stability in solution is confirmed by the molecular dynamics simulation. Immunomodulation has shown that this protein causes an immune reaction and, correspondingly, may serve a vaccine prototype.
Авторлар туралы
A. Ivanovsky
Shubnikov Institute of Crystallography, Federal Scientific Research Centre “Crystallography and Photonics,” Russian Academy of Sciences, 119333, Moscow, Russia
Email: a.1wanowskiy@gmail.com
Россия, Москва
I. Kolesnikov
National Research Centre “Kurchatov Institute”, 123182, Moscow, Russia
Email: a.1wanowskiy@gmail.com
Россия, Москва
Yu. Kordonskaya
National Research Centre “Kurchatov Institute”, 123182, Moscow, Russia; Shubnikov Institute of Crystallography, Federal Scientific Research Centre “Crystallography and Photonics,” Russian Academy of Sciences, 119333, Moscow, Russia
Email: a.1wanowskiy@gmail.com
Россия, Москва; Россия, Москва
A. Ermakov
National Research Centre “Kurchatov Institute”, 123182, Moscow, Russia
Email: a.1wanowskiy@gmail.com
Россия, Москва
M. Marchenkova
National Research Centre “Kurchatov Institute”, 123182, Moscow, Russia; Shubnikov Institute of Crystallography, Federal Scientific Research Centre “Crystallography and Photonics,” Russian Academy of Sciences, 119333, Moscow, Russia
Email: a.1wanowskiy@gmail.com
Россия, Москва; Россия, Москва
V. Timofeev
National Research Centre “Kurchatov Institute”, 123182, Moscow, Russia; Shubnikov Institute of Crystallography, Federal Scientific Research Centre “Crystallography and Photonics,” Russian Academy of Sciences, 119333, Moscow, Russia
Email: a.1wanowskiy@gmail.com
Россия, Москва; Россия, Москва
Yu. Pisarevsky
Shubnikov Institute of Crystallography, Federal Scientific Research Centre “Crystallography and Photonics,” Russian Academy of Sciences, 119333, Moscow, Russia; National Research Centre “Kurchatov Institute”, 123182, Moscow, Russia
Email: a.1wanowskiy@gmail.com
Россия, Москва; Россия, Москва
Yu. Dyakova
National Research Centre “Kurchatov Institute”, 123182, Moscow, Russia
Email: a.1wanowskiy@gmail.com
Россия, Москва
M. Kovalchuk
National Research Centre “Kurchatov Institute”, 123182, Moscow, Russia; Shubnikov Institute of Crystallography, Federal Scientific Research Centre “Crystallography and Photonics,” Russian Academy of Sciences, 119333, Moscow, Russia
Хат алмасуға жауапты Автор.
Email: a.1wanowskiy@gmail.com
Россия, Москва; Россия, Москва
Әдебиет тізімі
- Chan J.F.-W., Yuan S., Kok K.-H. et al. // Lancet. 2020. V. 395. № 10223. P 514. https://doi.org/10.1016/S0140-6736(20)30154-9
- Zhu N., Zhang D., Wang W. et al. // N. Engl. J. Med. 2020. V. 382. P. 727. https://doi.org/10.1056/NEJMoa2001017
- WHO (2020) Coronavirus Disease (COVID-19) Dashboard. World Heal. Organ.
- Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected: interim guidance, WHO, 2020, 28 January.
- Randhawa G.S., Soltysiak M.P.M., El Roz H. et al. // PLoS ONE. 2020. V. 16 (1). E. 0232391. https://doi.org/10.1371/journal.pone.0232391
- Dongwan K., Lee J.-Y., Yang J.-S. et al. // Cell. 2020. V. 181. № 4. P. 914. https://doi.org/10.1016/j.cell.2020.04.011
- WHO Draft Landscape of COVID-19 Candidate Vaccines. WHO, Geneva-2020.
- Smith Trevor R.F., Patel A., Ramos S. et al. // Nat. Commun. 2020. V. 11. P. 2610. https://doi.org/10.1038/s41467-020-16505-0
- Mulligan Mark J., Lyke K.E., Kitchin N. et al. // Nature. 2020. V. 586. P. 589. https://doi.org/10.1038/s41586-020-2639-4
- Zhu F.-C., Guan X.-H., Li Y.-H. et al. // Lancet. 2020. V. 396. № 10249. P. 479. https://doi.org/10.1016/S0140-6736(20)31605-6
- Gao Q., Bao L., Mao H. et al. // Science. 2020. V. 369. № 6499. P. 77.
- Cao Y., Yisimayi A., Jian F. et al. // Nature. 2022. V. 608. P. 593. https://doi.org/10.1038/s41586-022-04980-y
- Gallagher T.M., Buchmeier M.J. // Virology. 2001. V. 279. № 2. P. 371. https://doi.org/10.1006/viro.2000.0757
- https://pymol.org/2/
- Abraham M.J., Murtola T., Schulz R. et al. // SoftwareX. 2015. V. 1. P. 19. https://doi.org/10.1016/j.softx.2015.06.001
- Lindorff-Larsen K., Piana S., Palmo K. et al. // Proteins. 2010. V. 78. P. 1950. https://doi.org/10.1002/prot.22711
- Berendsen H.J.C., Postma J.P.M., van Gunsteren W.F. et al. // J. Chem. Phys. 1984. V. 81. № 8. P. 3684. https://doi.org/10.1063/1.448118
- Parrinello M., Rahman A. // J. Chem. Phys. 1982. V. 76. № 5. P. 2662. https://doi.org/10.1063/1.443248
- Hess B., Bekker H., Herman J.C. et al. // J. Comput. Chem. 1997. V. 18. P. 1463. https://doi.org/10.1002/(SICI)1096
- Darden T., York D., Pedersen L. // J. Chem. Phys. 1993. V. 98. № 12. P. 10089. https://doi.org/10.1063/1.464397
- https://kraken.iac.rm.cnr.it/C-IMMSIM/index.php
- Luckheeram R.V., Zhou R., Verma A.D., Xia B. // J. Immunol. Res. 2012. Art. 925135. https://doi.org/10.1155/2012/925135
- Rapin N., Lund O., Bernaschi M., Castiglione F. // PubMed. 2010. https://doi.org/10.1371/journal.pone.000986
